Creative Biomart Blog

Tue, 2026/06/16

IL-4 May Help “Rejuvenate” the Aging Hematopoietic System

The study shows that activation of the IL-4–FLT3–STAT6 signaling axis in multipotent progenitors, or MPPs, can restore lymphocyte production under conditions of inflammation and aging. Aging, Inflammation, and Hematopoietic Imbalance Chronic inflammation and aging disrupt hematopoietic balance, driving a process known as myeloid skewing. In this state, hematopoietic stem and progenitor cells, or HSPCs, preferentially generate myeloid cells, while the production of lymphoid cells is suppressed. This imbalance can create a self-reinforcing cycle. Expanded myeloid cells continue to se

Tue, 2026/06/16

FGF21 Activates the Cell’s “Cleanup” System to Reverse Aging and Enhance Therapeutic Efficacy

The study shows that FGF21 can partially upregulate TFE3-mediated autophagy flux through the FGFR1–SIRT1–MTOR signaling pathway. This restores the vitality of adipose-derived mesenchymal stem cells, or ASCs, enhances their potential to differentiate into neural stem cells, and ultimately improves the therapeutic efficacy of ASC transplantation for acute intracerebral hemorrhage. Intracerebral Hemorrhage and the Need for New Therapies Intracerebral hemorrhage, or ICH, is a neurological disease characterized by high mortality, and there is currently no definitive cure. Studies have s

Tue, 2026/06/16

Can Lifespan Be “Read Out”?

-Nature Builds a Cross-Species Transcriptomic Clock to Predict Aging and Mortality Risk This study not only systematically maps a conserved molecular blueprint of aging and reveals its modular, decomposable nature, but also provides a powerful tool for aging research. Aging, Lifespan, and the Search for Molecular Clues Aging is accompanied by functional decline and an increased risk of death. Although diet, drugs, and genes are known to regulate lifespan, the shared molecular mechanisms behind these effects have remained something of a “black box.” At the same time, accurate biomar

Tue, 2026/06/16

Anticancer Antibodies Enter Tumors but “Lose Their Way”: A New Platform Identifies Physical Barriers in the Tumor Microenvironment

This study is the first to visually reveal, at single-cell resolution in human solid tumor tissues, the “spatial confrontation” between therapeutic antibodies and the tumor microenvironment. Antibody Drugs and the Challenge of Solid Tumor Treatment Antibody drugs are regarded as important weapons in precision cancer therapy. These drugs can specifically recognize targets on the surface of tumor cells and, in theory, achieve a form of “precision strike.” However, in clinical practice, many antibody drugs have shown far less efficacy against solid tumors than expected. He

Tue, 2026/05/05

Why Can Some People’s Brains Quickly Clear a Virus After a Mosquito Bite, While Others Carry It Long-Term?

This study used human brain organoids to show that West Nile virus infection can follow two patterns: early clearance or long-term persistence. The virus mainly attacks neurons and astrocytes and triggers the release of multiple inflammatory factors, offering a new perspective for understanding viral encephalitis. Every summer, mosquito bites are hard to avoid. Most people only feel itchy, put up with it for a while, and then move on. But what you may not know is that a virus called West Nile virus can be hidden in the mouthparts of some mosquitoes. Most people feel little or nothing after inf

Tue, 2026/05/05

Cysteine’s “One Carbon, Two Uses”: The Metabolic Switch That Determines CD8+ T Cell Proliferation and Cancer-Killing Power

Research shows that cysteine—an amino acid and one of the basic building blocks of life—is essential for T cells, but it is used in different ways. Once inside the cell, the supply of cysteine is divided between two internal pathways, each driving different T cell behaviors. A research team from the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Bloomberg School of Public Health has discovered how CD8+ T cells in the immune system use the nutrient cysteine to regulate two key functions that compete for this resourc

Tue, 2026/05/05

New Hope Emerges in Pancreatic Cancer Treatment

Pancreatic cancer has long been notorious as the “king of cancers.” Globally, its incidence has continued to rise over the past several decades, with particularly notable growth among younger populations. In the coming years, pancreatic cancer is expected to become the second leading cause of cancer death in developed countries, behind only lung cancer. Even more discouraging is the fact that the five-year survival rate after diagnosis has long hovered around 10%. Over the past 40 years, drug treatment for this disease has seen almost no substantive progress. Recently, however, res

Tue, 2026/05/05

A New Mechanism of RIPK1 Ubiquitination Regulating Cell Death and Inflammatory Responses

The findings show that the RIPK1^K376R mutant not only induces kinase activity-dependent cell death during embryonic development, but also activates the NLRP3 inflammasome in adulthood through RIPK3-mediated metabolic reprogramming, thereby promoting kinase activity-independent inflammation driven by its scaffold function. Receptor-interacting protein kinase 1, or RIPK1, is a key regulator of cell death and inflammation, and its activity is controlled by various post-translational modifications. Although previous studies have shown that ubiquitination of lysine 376, or K376, in RIPK1 can suppr